{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:11:19Z","timestamp":1783930279772,"version":"3.55.0"},"reference-count":17,"publisher":"Tsinghua University Press","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.26599\/1671-5411.2026.05.008","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:46:42Z","timestamp":1783928802000},"page":"317-321","source":"Crossref","is-referenced-by-count":0,"title":["Unexplained heart failure with preserved ejection fraction diagnosed as amyloidosis of the heart"],"prefix":"10.26599","volume":"23","author":[{"given":"Min-Min","family":"WANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Xia","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yao","family":"CHENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"MD Benson","year":"2020","unstructured":"MD Benson. Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. 2020, 27: 217-222.","journal-title":"Amyloid"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis","volume":"385","author":"E Kastritis","year":"2021","unstructured":"E Kastritis. Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. 2021, 385: 46-58.","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"TP Quock","year":"2018","unstructured":"TP Quock. Epidemiology of AL amyloidosis: a real-world study using US claims data. 2018, 2: 1046-1053.","journal-title":"Blood Adv"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"VS Hahn","year":"2020","unstructured":"VS Hahn. Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis. 2020, 8: 712-724.","journal-title":"JACC Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","article-title":"Diagnostic imaging of cardiac amyloidosis","volume":"17","author":"A Martinez-Naharro","year":"2020","unstructured":"A Martinez-Naharro. Diagnostic imaging of cardiac amyloidosis. 2020, 17: 413-426.","journal-title":"Nat Rev Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e000029","DOI":"10.1161\/HCI.0000000000000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging","volume":"14","author":"S Dorbala","year":"2021","unstructured":"S Dorbala. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. 2021, 14: e000029.","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"Itc33","DOI":"10.7326\/AITC202303210","article-title":"Cardiac Amyloidosis","volume":"176","author":"MW Bloom","year":"2023","unstructured":"MW Bloom. Cardiac Amyloidosis. 2023, 176: Itc33-itc48.","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1148\/radiol.2021212214","article-title":"The Clinical Significance of Cardiac MRI Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy","volume":"302","author":"K Hanneman","year":"2022","unstructured":"K Hanneman. The Clinical Significance of Cardiac MRI Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy. 2022, 302: 307-308.","journal-title":"Radiology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jacc.2010.03.083","article-title":"Iron overload cardiomyopathy: better understanding of an increasing disorder","volume":"56","author":"P Gujja","year":"2010","unstructured":"P Gujja. Iron overload cardiomyopathy: better understanding of an increasing disorder. 2010, 56: 1001-1012.","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2018.01.016","author":"","unstructured":"","journal-title":"null"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12574-020-00508-3","article-title":"Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain","volume":"19","author":"H Tanaka","year":"2021","unstructured":"H Tanaka. Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. 2021, 19: 71-79.","journal-title":"J Echocardiogr"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"E Arbelo","year":"2023","unstructured":"E Arbelo. 2023 ESC Guidelines for the management of cardiomyopathies. 2023, 44: 3503-3626.","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1148\/radiol.2018172613","article-title":"Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy","volume":"288","author":"GR Karur","year":"2018","unstructured":"GR Karur. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy. 2018, 288: 398-406.","journal-title":"Radiology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"P Garcia-Pavia","year":"2021","unstructured":"P Garcia-Pavia. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. 2021, 23: 512-526.","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.mayocp.2018.08.006","article-title":"A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing","volume":"94","author":"E Muchtar","year":"2019","unstructured":"E Muchtar. A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing. 2019, 94: 472-83.","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/CM9.0000000000002961","article-title":"Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis","volume":"137","author":"K Shen","year":"2024","unstructured":"K Shen. Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis. 2024, 137: 127-129.","journal-title":"Chin Med J (Engl)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajh.27177","article-title":"Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment","volume":"99","author":"MA Gertz","year":"2024","unstructured":"MA Gertz. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment. 2024, 99: 309-324.","journal-title":"Am J Hematol"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:46:43Z","timestamp":1783928803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2026.05.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2026.05.008","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}